Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 11-01-2023 | Practice Area: | Corporate and M&A |
| Deal Title: | Sirio Pharma acquisition of Majority Stake in Best Formulations | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Sirio Pharma Co., Ltd. in connection with its acquisition of a majority stake of Best Formulations. Sirio Pharma acquired Best Formulations as part of its strategy to meet the production needs of both international and local brands, as well as expanded capacity, global research and development collaboration, local market insights and diversification of products and services.
|
||
| Financial Center: | Beijing | Value: | 0.00-0.00 |
| Advised Party: | Acquiror | Law Firm | Davis Polk |
| Target Company Jurisdiction: | United States | Acquiror Jurisdiction: | China |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Howard Zhang |
